CN101443332B - 抗病毒嘧啶核苷衍生物 - Google Patents

抗病毒嘧啶核苷衍生物 Download PDF

Info

Publication number
CN101443332B
CN101443332B CN2007800169982A CN200780016998A CN101443332B CN 101443332 B CN101443332 B CN 101443332B CN 2007800169982 A CN2007800169982 A CN 2007800169982A CN 200780016998 A CN200780016998 A CN 200780016998A CN 101443332 B CN101443332 B CN 101443332B
Authority
CN
China
Prior art keywords
compound
valine
pentyl
hexyl
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN2007800169982A
Other languages
English (en)
Chinese (zh)
Other versions
CN101443332A (zh
Inventor
克里斯托弗·麦圭甘
扬·巴尔扎利尼
马尔科·米格里奥雷
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Katholieke Universiteit Leuven
University College Cardiff Consultants Ltd
Original Assignee
Katholieke Universiteit Leuven
University College Cardiff Consultants Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Katholieke Universiteit Leuven, University College Cardiff Consultants Ltd filed Critical Katholieke Universiteit Leuven
Publication of CN101443332A publication Critical patent/CN101443332A/zh
Application granted granted Critical
Publication of CN101443332B publication Critical patent/CN101443332B/zh
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CN2007800169982A 2006-05-09 2007-05-09 抗病毒嘧啶核苷衍生物 Expired - Fee Related CN101443332B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0609178.9 2006-05-09
GBGB0609178.9A GB0609178D0 (en) 2006-05-09 2006-05-09 Novel compounds
PCT/GB2007/001677 WO2007129083A1 (en) 2006-05-09 2007-05-09 Anti-viral pyrimidine nucleoside derivatives

Publications (2)

Publication Number Publication Date
CN101443332A CN101443332A (zh) 2009-05-27
CN101443332B true CN101443332B (zh) 2011-11-09

Family

ID=36637171

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2007800169982A Expired - Fee Related CN101443332B (zh) 2006-05-09 2007-05-09 抗病毒嘧啶核苷衍生物

Country Status (22)

Country Link
US (3) US8329664B2 (https=)
EP (1) EP2016081B1 (https=)
JP (1) JP5261374B2 (https=)
KR (1) KR101447522B1 (https=)
CN (1) CN101443332B (https=)
AT (1) ATE506367T1 (https=)
AU (1) AU2007246814B2 (https=)
BR (1) BRPI0711354A2 (https=)
CA (1) CA2656780C (https=)
CY (1) CY1111711T1 (https=)
DE (1) DE602007014030D1 (https=)
DK (1) DK2016081T3 (https=)
EA (1) EA015178B1 (https=)
ES (1) ES2365057T3 (https=)
GB (1) GB0609178D0 (https=)
IL (1) IL194806A (https=)
NZ (1) NZ573377A (https=)
PL (1) PL2016081T3 (https=)
PT (1) PT2016081E (https=)
SI (1) SI2016081T1 (https=)
TW (1) TWI385172B (https=)
WO (1) WO2007129083A1 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0009486D0 (en) * 2000-04-17 2000-06-07 Univ Cardiff Chemical compounds
GB2452556A (en) * 2007-09-07 2009-03-11 Univ Leuven Kath Nucleoside analogues esterified at 3 and/or 5 positions by neutral non-polar amino acid, or oligopeptide thereof, for combating Varicella Zoster virus
US9260469B2 (en) * 2010-10-09 2016-02-16 Contravir Pharmaceuticals, Inc. Method of preparation of antiviral compounds and useful intermediates thereof
CN102443032B (zh) * 2010-10-09 2015-07-22 英希比泰克斯公司 制备抗病毒组合物的方法及其中间体的应用
MD4110C1 (ro) * 2010-10-21 2011-12-31 Валериу РУДИК Preparat antiherpetiс
KR101875997B1 (ko) * 2015-05-04 2018-07-06 엔 앤드 엔 파마세우티칼스 인크. 엔-메탄노카르바티미딘을 이용한 대상포진의 치료방법

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20010018440A1 (en) * 1996-11-15 2001-08-30 Yale University And The University Of Georgia Research Foundation, Inc. L-beta-dioxolane uridine analogs and methods for treating and preventing virus infections

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62255499A (ja) 1986-04-28 1987-11-07 Teijin Ltd 螢光性ヌクレオシド又はヌクレオチド
EP0346108A3 (en) 1988-06-09 1991-04-24 The Wellcome Foundation Limited Anti-infective nucleosides
YU43193A (sh) 1992-06-22 1997-01-08 Eli Lilly And Company 2'-deoksi-2',2'-difluoro(4-supstituisani)pirimidinski nukleozidi antivirusnog i antikancerogenog dejstva i međuproizvodi
GB9505025D0 (en) 1995-03-13 1995-05-03 Medical Res Council Chemical compounds
GB9708611D0 (en) 1997-04-28 1997-06-18 Univ Cardiff Chemical compounds
GB9716231D0 (en) 1997-07-31 1997-10-08 Amersham Int Ltd Base analogues
HK1053126A1 (zh) 1999-07-22 2003-10-10 新生物生物公司 酶催化的治疗活化
BR0012676A (pt) 1999-07-22 2003-07-01 Newbiotics Inc Métodos para tratamento de tumores resistentes a terapia
MXPA02000761A (es) 1999-07-22 2002-08-12 Newbiotics Inc Agentes terapeuticos anti-infecciosos catalizados por enzima.
GB0009486D0 (en) * 2000-04-17 2000-06-07 Univ Cardiff Chemical compounds
GB0011203D0 (en) * 2000-05-09 2000-06-28 Univ Cardiff Chemical compounds
US6875751B2 (en) * 2000-06-15 2005-04-05 Idenix Pharmaceuticals, Inc. 3′-prodrugs of 2′-deoxy-β-L-nucleosides
MY141594A (en) * 2000-06-15 2010-05-14 Novirio Pharmaceuticals Ltd 3'-PRODRUGS OF 2'-DEOXY-ß-L-NUCLEOSIDES
TW200500375A (en) * 2002-06-28 2005-01-01 Idenix Cayman Ltd Modified 2' and 3'-nucleoside prodrugs for treating flaviviridae
WO2004084453A2 (en) 2003-03-20 2004-09-30 Microbiologica Quimica E Farmaceutica Ltd. METHODS OF MANUFACTURE OF 2'-DEOXY-β-L-NUCLEOSIDES
US20050137141A1 (en) 2003-10-24 2005-06-23 John Hilfinger Prodrug composition
CA2566541C (en) 2004-06-07 2012-10-09 Anadys Pharmaceuticals, Inc. 3-.beta.-d-ribofuranosylthiazolo[4,5-d]pyrimidine nucleosides and uses thereof

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20010018440A1 (en) * 1996-11-15 2001-08-30 Yale University And The University Of Georgia Research Foundation, Inc. L-beta-dioxolane uridine analogs and methods for treating and preventing virus infections

Also Published As

Publication number Publication date
CY1111711T1 (el) 2015-10-07
KR101447522B1 (ko) 2014-10-06
US20100222295A1 (en) 2010-09-02
EA200870505A1 (ru) 2009-04-28
PL2016081T3 (pl) 2011-12-30
KR20090042204A (ko) 2009-04-29
EP2016081A1 (en) 2009-01-21
JP5261374B2 (ja) 2013-08-14
ATE506367T1 (de) 2011-05-15
ES2365057T3 (es) 2011-09-21
DK2016081T3 (da) 2011-06-20
IL194806A (en) 2015-08-31
EP2016081B1 (en) 2011-04-20
CA2656780C (en) 2015-04-28
NZ573377A (en) 2011-03-31
US20130096079A1 (en) 2013-04-18
US8859512B2 (en) 2014-10-14
GB0609178D0 (en) 2006-06-21
US8329664B2 (en) 2012-12-11
CN101443332A (zh) 2009-05-27
WO2007129083A1 (en) 2007-11-15
AU2007246814B2 (en) 2012-07-19
US20150072948A1 (en) 2015-03-12
CA2656780A1 (en) 2007-11-15
JP2009536188A (ja) 2009-10-08
BRPI0711354A2 (pt) 2011-09-27
TWI385172B (zh) 2013-02-11
AU2007246814A1 (en) 2007-11-15
TW200813066A (en) 2008-03-16
SI2016081T1 (sl) 2011-09-30
US9427447B2 (en) 2016-08-30
DE602007014030D1 (de) 2011-06-01
IL194806A0 (en) 2009-09-22
EA015178B1 (ru) 2011-06-30
PT2016081E (pt) 2011-06-28

Similar Documents

Publication Publication Date Title
AU2018378832B9 (en) N4-hydroxycytidine and derivatives and anti-viral uses related thereto
US10577337B2 (en) Compositions and methods of treatment with prodrugs of tizoxanide, an analogue or salt thereof
KR101612642B1 (ko) 테노포비어 알라펜아미드 헤미푸마레이트
JP5271913B2 (ja) 化合物
JP4959900B2 (ja) 抗ウイルスピリミジンヌクレオシド類
CN101443332B (zh) 抗病毒嘧啶核苷衍生物
KR20180039666A (ko) 항바이러스제로서 유용한 피롤로피리미딘 뉴클레오시드 및 그의 유사체
JP2002525374A (ja) 抗ウイルスプリン誘導体
KR102502749B1 (ko) 간 전달 엔테카비어 프로드러그 뉴클레오티드 시클로 포스페이트 화합물 및 응용
ITMI951450A1 (it) Esteri acilici di amminoacidi achirali di gangiclovir e relativi derivati
EP1123935B1 (en) 3'-Fluorinated guanosine derivatives for the treatment or prophylaxis of HBV or retroviral infections
ES2488821T3 (es) Proceso de preparación de un compuesto antiviral
EP1058687B1 (en) Nucleosides
JPWO2020045628A1 (ja) 核酸アナログ及び抗ｂ型肝炎ウイルス剤
US8076302B2 (en) Pyrimidine nucleoside derivatives and salts thereof
US20070135436A1 (en) Chemical compounds
ES2829254T3 (es) Nucleósidos de pirrolopirimidina y análogos de los mismos útiles como agentes antivíricos
WO2016169908A1 (en) Uracil derivatives for the treatment of malaria
JP4964473B2 (ja) ピリミジンヌクレオシド誘導体及びその塩
WO2026052118A1 (zh) 化合物102d-6晶型及其制备方法和酰乙酯多环化合物制备方法

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20111109

Termination date: 20180509